Millions of People Could Live Thanks to New Access to Tuberculosis Medication – Mother Jones

Johnson & Johnson announced on Friday that the company will not enforce patents for the lifesaving tuberculosis treatment bedaquiline in 134 low- and middle-income countries globally. Bedaquiline, which was approved in 2012, is an essential part of treatment for multidrug-resistant tuberculosis, also known as MDR-TB. MDR-TB impacts half a million people annually, and 200,000 of…

http://nedhamsonsecondlineviewofthenews.com/2023/10/01/millions-of-people-could-live-thanks-to-new-access-to-tuberculosis-medication-mother-jones/